Washington [US], September 2 (ANI): Researchers have published results that show encouraging therapeutic options for patients with blood cancer and multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two
Washington DC [USA], Dec 30 (ANI): A study has recently found that taking a higher dose of Carfilzomib, which is used for treating cancer, can increase the risk of hypertension, heart failure, and heart attacks in multiple myeloma patients.